Insider Transactions in Q1 2025 at Brainstorm Cell Therapeutics Inc. (BCLI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2025
|
Ibrahim B. Dagher Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+42.79%
|
-
|
|
Jan 01
2025
|
Anthony J. Polverino Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+48.26%
|
-
|
|
Jan 01
2025
|
Jacob A Frenkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+47.75%
|
-
|
|
Jan 01
2025
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+37.39%
|
-
|
|
Jan 01
2025
|
Irit Arbel Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,666
+42.76%
|
-
|
|
Jan 01
2025
|
Menghisteab Bairu Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+50.0%
|
-
|
|
Jan 01
2025
|
Hartoun Hartounian EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.02%
|
-
|
|
Jan 01
2025
|
Stacy Lindborg Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+29.31%
|
-
|
|
Jan 01
2025
|
Nir Naor Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,666
+49.36%
|
-
|
|
Jan 01
2025
|
Alla Patlis Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+47.42%
|
-
|
|
Jan 01
2025
|
Uri Yablonka EVP & Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+33.91%
|
-
|